相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis
Yuli Guzman-Prado et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication
Charupong Saengboonmee et al.
CANADIAN JOURNAL OF DIABETES (2021)
Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
Nattaporn Phanthaphol et al.
FRONTIERS IN ONCOLOGY (2021)
Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma
Xiaodong Jia et al.
HEPATOLOGY (2020)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Oliver Clements et al.
JOURNAL OF HEPATOLOGY (2020)
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012
Andrea A. Florio et al.
CANCER (2020)
Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women
Jessica L. Petrick et al.
HEPATOLOGY (2020)
Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer
Benjamin D. Hopkins et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
Mirella Pastore et al.
CELLS (2020)
Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank
Jessica L. Petrick et al.
BRITISH JOURNAL OF CANCER (2020)
Adiponectin Is Inversely Associated With Tumour Grade in Colorectal Cancer Patients
Rita Polito et al.
ANTICANCER RESEARCH (2020)
Globular adiponectin antagonizes leptin-induced growth of cancer cells by modulating inflammasomes activation: Critical role of HO-1 signaling
Pawan Kumar Raut et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Adiponectin receptor activation inhibits prostate cancer xenograft growth
Lisa K. Philp et al.
ENDOCRINE-RELATED CANCER (2020)
The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis
Lilong Zhang et al.
BMC CANCER (2020)
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Alison E. Ringel et al.
CELL (2020)
NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells
Charupong Saengboonmee et al.
LIFE SCIENCES (2020)
Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin
Yuhao Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
Stefania De Lorenzo et al.
CANCERS (2020)
Role of Leptin in Neoplastic and Biliary Tree Disease
Paolo Izzo et al.
IN VIVO (2020)
Impact of body mass index on tumor recurrence among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma- a multi-institutional international analysis
Katiuscha Merath et al.
EJSO (2019)
The microbiome, cancer, and cancer therapy
Beth A. Helmink et al.
NATURE MEDICINE (2019)
Obesity: global epidemiology and pathogenesis
Matthias Blueher
NATURE REVIEWS ENDOCRINOLOGY (2019)
Influence of the body mass index on postoperative outcome and long-term survival after pancreatic resections in patients with underlying malignancy
Philippa Seika et al.
HEPATOBILIARY SURGERY AND NUTRITION (2019)
Obesity and liver cancer
Carlo Saitta et al.
ANNALS OF HEPATOLOGY (2019)
Effects of high-fat diet-induced adipokines and cytokines on colorectal cancer development
Jian Zhang et al.
FEBS OPEN BIO (2019)
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
Francesca Corti et al.
CANCER TREATMENT REVIEWS (2019)
The obese adipose tissue microenvironment in cancer development and progression
Daniela F. Quail et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Metabolic adaptation and maladaptation in adipose tissue
Edward T. Chouchani et al.
NATURE METABOLISM (2019)
Association between metabolic syndrome and hepatobiliary cancers: A case-control study
Shyam Menon et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2019)
Leptin and the endocrine control of energy balance
Jeffrey M. Friedman
NATURE METABOLISM (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
Javier Vaquero et al.
CLINICAL CANCER RESEARCH (2018)
IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma
Chunyan Yue et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis
Jessica L. Petrick et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Benjamin D. Hopkins et al.
NATURE (2018)
Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case-control study in China
Jianping Xiong et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors
Ernst Lengyel et al.
TRENDS IN CANCER (2018)
Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma
Dan Hogdall et al.
TRENDS IN CANCER (2018)
Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma
Shinya Okumura et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort
Baiyu Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4
Jihua Nie et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Adapting to obesity with adipose tissue inflammation
Shannon M. Reilly et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Obesity and the tumor microenvironment
Oakley C. Olson et al.
SCIENCE (2017)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
Jessica L. Petrick et al.
PLOS ONE (2017)
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
Nicha Wongjarupong et al.
BMC GASTROENTEROLOGY (2017)
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang et al.
CANCER CELL (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions
Ahmed Abdel-Razik et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Obesity, Inflammation, and Cancer
Tuo Deng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies
Jennifer W. Wu et al.
DIABETES CARE (2016)
Aspirin use and the risk of cholangiocarcinoma
Jonggi Choi et al.
HEPATOLOGY (2016)
The Association Between Non-Alcoholic Steatohepatitis and Intrahepatic Cholangiocarcinoma: A Hospital Based Case-Control Study
Masahiko Kinoshita et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
Nicole E. Scharping et al.
VACCINES (2016)
Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma Association of diabetes mellitus and cholangiocarcinoma
Charupong Saengboonmee et al.
CANCER EPIDEMIOLOGY (2015)
Nutrient-sensing mechanisms and pathways
Alejo Efeyan et al.
NATURE (2015)
Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: A case-control study in Korea
Ban Seok Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Risk factors for perihilar cholangiocarcinoma: A hospital-based case-control study
Ban Seok Lee et al.
LIVER INTERNATIONAL (2015)
Adiposity and cancer risk: new mechanistic insights from epidemiology
Andrew G. Renehan et al.
NATURE REVIEWS CANCER (2015)
Why Does Infection With Some Helminths Cause Cancer?
Paul J. Brindley et al.
TRENDS IN CANCER (2015)
Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression
Anchalee Techasen et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Obesity and the risk of cholangiocarcinoma: a meta-analysis
Jun-Shan Li et al.
TUMOR BIOLOGY (2014)
New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases
Ersilia Nigro et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome
Jordan L. Plieskatt et al.
FASEB JOURNAL (2013)
Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
Roongruedee Chaiteerakij et al.
HEPATOLOGY (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
Darlene E. Berryman et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers
Hirokazu Ohashi et al.
CANCER SCIENCE (2012)
Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis
Wei Jing et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
William C. Palmer et al.
JOURNAL OF HEPATOLOGY (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
Elevated Plasma IL-6 Associates with Increased Risk of Advanced Fibrosis and Cholangiocarcinoma in Individuals Infected by Opisthorchis viverrini
Banchob Sripa et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Metabolic Syndrome Increases the Risk of Primary Liver Cancer in the United States: A Study in the SEER-Medicare Database
Tania M. Welzel et al.
HEPATOLOGY (2011)
Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines
Ling Xu et al.
BMC CANCER (2010)
Estrogen Stimulates Female Biliary Epithelial Cell Interleukin-6 Expression in Mice and Humans
Kumiko Isse et al.
HEPATOLOGY (2010)
Adiponectin Receptor Expression in Human Malignant Tissues
Sharon H. Chou et al.
Hormones & Cancer (2010)
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom
M. J. Grainge et al.
BRITISH JOURNAL OF CANCER (2009)
Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor
A. Mancino et al.
DIGESTIVE AND LIVER DISEASE (2009)
Leptin enhances cholangiocarcinoma cell growth
Giammarco Fava et al.
CANCER RESEARCH (2008)
Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification
Seiji Ishiguro et al.
CANCER CAUSES & CONTROL (2008)
Risk factors for intrahepatic and extrahepatic Cholangiocarcinoma in the United States: A population-based case-control study
Tania M. Welzelt et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study
Tania M. Welzel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma
Natini Jinawath et al.
HEPATOLOGY (2006)
Relation of body mass index to cancer risk in 362,552 Swedish men
Claudine Samanic et al.
CANCER CAUSES & CONTROL (2006)
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma
Domenico Alvaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Obesity and cancer risk among white and black United States veterans
C Samanic et al.
CANCER CAUSES & CONTROL (2004)
Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats
D Alvaro et al.
GASTROENTEROLOGY (2000)
分享论文
